STAT+: Democrats call on FTC to investigate AbbVie’s Humira pricing strategy

WASHINGTON — Three powerful Democrats wrote to the Federal Trade Commission Tuesday urging them to investigate whether drug maker AbbVie violated the law in trying to keep cheaper versions of its blockbuster drug Humira off the market.

The surprise announcement came in the first minutes of a Tuesday hearing held by the House Oversight Committee investigating the company’s pricing practices. AbbVie’s CEO Richard Gonzalez is testifying.

Continue to STAT+ to read the full story…

STAT+: Democrats call on FTC to investigate AbbVie’s Humira pricing strategy

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top